Prasugrel (Effient)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 01:15, 15 August 2017 by Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y<sub>12</sub> class of adenosine diphosphate (ADP) receptors on platelets, inhib...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

Class/mechanism: Irreversible thienopyridine class inhibitor of the P2Y12 class of adenosine diphosphate (ADP) receptors on platelets, inhibiting platelet activation and aggregation.
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.

Also known as

  • Brand names: Effient, Efient, Glitax, Prasita, Prasudoc, PrasuSafe, Prax, Surfent, Targol